Frontage Names Dr. Abdul Mutlib as President of Canadian Operations

Frontage Laboratories

EXTON, PA — Frontage Holdings Corporation has announced the appointment of Dr. Abdul Mutlib as President of Frontage Laboratories, Canada, marking a strategic step in the organization’s global expansion. Dr. Mutlib, who will also continue as Chief Scientific & Strategy Officer for Frontage Laboratories, will oversee operations in Toronto and Vancouver while driving growth and innovation in the Canadian market.

With more than 35 years of experience in research and development, including leadership roles in major pharmaceutical companies and contract research organizations (CROs), Dr. Mutlib brings valuable expertise to his new position. His appointment reinforces Frontage’s commitment to becoming a leading partner and service provider to Canada’s rapidly growing biotech and pharmaceutical sectors.

READ:  Heidi Carlson Named Director of Chester County Department of Aging Services

Dr. Wentao Zhang, Co-Chief Executive Officer of Frontage Holdings, underscored the significance of this leadership move. “Abdul’s leadership and experience has been vital to Frontage’s growth over the last several years. His vision and strong leadership qualities will drive our success and expansion in Canada,” said Dr. Zhang.

Dr. Mutlib expressed his gratitude and excitement for the opportunity. “I’m deeply honored by this opportunity. I have full confidence in our Canadian team, and together, we aim to expand our services and significantly grow the business in the coming years. I’m excited to collaborate with Canadian authorities and establish Frontage as a leading provider of comprehensive, high-quality R&D services, supporting Canada’s vision to become a dynamic hub for biotechnology and pharmaceutical innovation,” he stated.

READ:  Lancaster Native Joins Auditor General’s Office Through Intern to Hire Program

This appointment aligns with Frontage’s broader strategy to enhance its global service offerings and strengthen its position as a premier CRO. By focusing on innovation and collaboration, the company aims to bolster its contributions to the biotech industry, further cementing its role in fostering pharmaceutical advancements across Canada and beyond.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.